Prometheus Biosciences Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress
11. August 2022 16:00 ET
|
Prometheus Biosciences
- Both topline ARTEMIS-UC Phase 2 and full APOLLO-CD Phase 2a results expected concurrently in 4Q 2022 - - Bioavailability greater than 80% achieved upon completion of PRA023 subcutaneous bridging...
2,000 official plug-ins for Checkmk: Presenting the Prometheus Alert Manager
23. März 2022 10:56 ET
|
tribe29 GmbH
MUNICH, Germany, March 23, 2022 (GLOBE NEWSWIRE) -- tribe29, the company behind the Checkmk IT monitoring solution, today presented the Prometheus Alert Manager as its official Checkmk monitoring...
Prometheus Biosciences to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
05. Januar 2022 08:30 ET
|
Prometheus Biosciences
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,...
Prometheus Biosciences and Dr. Falk Pharma Advance PR600 and Trigger Final Preclinical Milestone Payment
03. Januar 2022 08:00 ET
|
Prometheus Biosciences
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Prometheus Biosciences, Inc. (Nasdaq: RXDX), a clinical-stage biotechnology company pioneering a precision medicine approach for the discovery,...
Prometheus Biosciences Reports Positive Topline Phase 1 Data on Lead Therapeutic Candidate PRA023; Expands Indications to Include Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD)
07. Dezember 2021 07:00 ET
|
Prometheus Biosciences
Phase 1 trial achieved primary objective of safety and tolerability and demonstrated favorable outcomes on other key endpoints, including target engagement and immunogenicity Discussion of Phase 1...
QOMPLX Announces Prometheus Integration for its High-Performance, Cost-Efficient Time Series Database
08. Juli 2021 10:14 ET
|
QOMPLX, Inc.
TYSONS, Va., July 08, 2021 (GLOBE NEWSWIRE) -- QOMPLX™ is proud to announce the integration of the popular and powerful systems monitoring & alerting toolkit Prometheus with TimeEngine, QOMPLX’s...
Grafana Labs Releases Grafana Metrics Enterprise, a Streamlined, Cost-Effective Way for Organizations to Run Prometheus at Enterprise Scale
17. September 2020 11:30 ET
|
Grafana
NEW YORK, Sept. 17, 2020 (GLOBE NEWSWIRE) -- Today, Grafana Labs announced the release of Grafana Metrics Enterprise, a modern Prometheus-as-a-Service solution designed for the scale, architecture,...
Grafana 7.0 Delivers Major Visualization Upgrades and Empowers Users to Unite & Transform Data from All Sources Ranging from Metrics and Logs to Traces and Beyond
18. Mai 2020 11:30 ET
|
Grafana
NEW YORK, May 18, 2020 (GLOBE NEWSWIRE) -- Today, Grafana Labs is announcing the general availability of Grafana 7.0 with significant enhancements to simplify the development of custom plugins and...
Sysdig Announces Expanded Prometheus Support Options
27. Februar 2018 06:00 ET
|
Sysdig
SAN FRANCISCO, Feb. 27, 2018 (GLOBE NEWSWIRE) -- Sysdig, Inc., the container intelligence company, today announced new customizable support packages for self-hosted Prometheus monitoring users....